Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated (CORT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CORT · as of Jun 8, 2026
Key Statistics
Explore Corcept Therapeutics Incorporated Data
cort stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 26 · Buy rate: 53.8%
The CORT analyst consensus is Buy, based on ratings from 26 Wall Street analysts over the past 3 months. The average 12-month price target is $83.00, representing +14.29% upside from the current price of $72.62.
Competitors & Peers
cort competitorsCORT
ABVX
AXSM
CAI
CYTK
HALOStock Performance
Full HistoryAbout Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offer…
what is corcept therapeutics incorporated · cort stock overview · corcept therapeutics incorporated company profile · who is corcept therapeutics incorporated ceo · cort NASDAQ · corcept therapeutics incorporated headquarters · corcept therapeutics incorporated business segments
About Stock Overview & Key Data
Corcept Therapeutics Incorporated (CORT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 14, 2004. As of the latest trading session, CORT stock price is $72.62, with a market capitalization of $7.8B. The stock has returned +2.90% over the past 12 months and +108.68% year-to-date.
According to 26 Wall Street analysts, the consensus rating for Corcept Therapeutics Incorporated stock is Buy, with an average 12-month price target of $83.00. In fiscal year 2025, Corcept Therapeutics Incorporated reported revenue of $761.4M and net income of $99.7M. For detailed data — including Corcept Therapeutics Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Corcept Therapeutics Incorporated (CORT) stock price is $72.62. The stock is traded on NASDAQ under the ticker symbol CORT. The 52-week range is $28.66 – $91.00.